EP3030142A4 - Intra-abdominal pressure to promote hemostasis and survival - Google Patents

Intra-abdominal pressure to promote hemostasis and survival Download PDF

Info

Publication number
EP3030142A4
EP3030142A4 EP14835065.5A EP14835065A EP3030142A4 EP 3030142 A4 EP3030142 A4 EP 3030142A4 EP 14835065 A EP14835065 A EP 14835065A EP 3030142 A4 EP3030142 A4 EP 3030142A4
Authority
EP
European Patent Office
Prior art keywords
intra
survival
abdominal pressure
promote hemostasis
hemostasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14835065.5A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3030142A1 (en
Inventor
Adam Rago
John Marini
Gregory T. Zugates
Marc Helmick
Upma Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arsenal Medical Inc
Original Assignee
Arsenal Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arsenal Medical Inc filed Critical Arsenal Medical Inc
Publication of EP3030142A1 publication Critical patent/EP3030142A1/en
Publication of EP3030142A4 publication Critical patent/EP3030142A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/12186Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00637Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00641Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closing fistulae, e.g. anorectal fistulae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00646Type of implements
    • A61B2017/00654Type of implements entirely comprised between the two sides of the opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00898Material properties expandable upon contact with fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B2017/12004Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for haemostasis, for prevention of bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
EP14835065.5A 2013-08-09 2014-08-08 Intra-abdominal pressure to promote hemostasis and survival Withdrawn EP3030142A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361864368P 2013-08-09 2013-08-09
PCT/US2014/050332 WO2015021375A1 (en) 2013-08-09 2014-08-08 Intra-abdominal pressure to promote hemostasis and survival

Publications (2)

Publication Number Publication Date
EP3030142A1 EP3030142A1 (en) 2016-06-15
EP3030142A4 true EP3030142A4 (en) 2017-08-09

Family

ID=52461959

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14835065.5A Withdrawn EP3030142A4 (en) 2013-08-09 2014-08-08 Intra-abdominal pressure to promote hemostasis and survival

Country Status (6)

Country Link
EP (1) EP3030142A4 (ja)
JP (1) JP2016531668A (ja)
AU (1) AU2014305771A1 (ja)
CA (1) CA2919856A1 (ja)
IL (1) IL244011A0 (ja)
WO (1) WO2015021375A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10293076B2 (en) 2011-08-12 2019-05-21 Arsenal Medical, Inc. Intra-abdominal pressure to promote hemostasis and survival
US9358042B2 (en) 2013-03-13 2016-06-07 The Spectranetics Corporation Expandable member for perforation occlusion
US10449336B2 (en) 2015-08-11 2019-10-22 The Spectranetics Corporation Temporary occlusions balloon devices and methods for preventing blood flow through a vascular perforation
US10499892B2 (en) 2015-08-11 2019-12-10 The Spectranetics Corporation Temporary occlusion balloon devices and methods for preventing blood flow through a vascular perforation
CN114929198A (zh) 2019-12-13 2022-08-19 麻省理工学院 作为上皮层疗法的聚合物的组织催化生长

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6520977B2 (en) * 1999-12-06 2003-02-18 Hadi Piraka Uterine balloon apparatus and method
US20040013715A1 (en) * 2001-09-12 2004-01-22 Gary Wnek Treatment for high pressure bleeding
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US10420862B2 (en) * 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
EP2741788A4 (en) * 2011-08-14 2015-03-25 Materials Modification Inc METHOD AND COMPOSITION FOR IN-SITU FORMATION OF AN ARTIFICIAL BARRIER FOR FIGHTING BLOOD LOSS
US8993831B2 (en) * 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MICHAEL DUGGAN ET AL: "Self-expanding polyurethane polymer improves survival in a model of noncompressible massive abdominal hemorrhage", JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, vol. 74, no. 6, 1 June 2013 (2013-06-01), US, pages 1462 - 1467, XP055351157, ISSN: 2163-0755, DOI: 10.1097/TA.0b013e31828da937 *

Also Published As

Publication number Publication date
JP2016531668A (ja) 2016-10-13
IL244011A0 (en) 2016-04-21
AU2014305771A1 (en) 2016-02-18
CA2919856A1 (en) 2015-02-12
EP3030142A1 (en) 2016-06-15
WO2015021375A1 (en) 2015-02-12

Similar Documents

Publication Publication Date Title
EP3043784A4 (en) Aryl ethers and uses thereof
EP3030566A4 (en) Aza-pyridone compounds and uses thereof
CA2874913A1 (en) Multi-stage well isolation and fracturing
EP3004833A4 (en) Improvements in and relating to tissue sampling
EP3062867A4 (en) Controlled pressure endoscopic and percutaneous surgery
EP2970909A4 (en) Methods and compositions related to t-cell activity
EP2983681A4 (en) Therapeutic compositions and uses thereof
EP3071236A4 (en) Injectable tissue supplement
EP3060724A4 (en) Improvements in and relating to couplers
EP3068443A4 (en) Residualizing linkers and uses thereof
EP3054974A4 (en) Glycan-interacting compounds and methods of use
EP3048108A4 (en) Thienopiperidine derivative and use thereof
EP3007557A4 (en) Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside
EP3037097A4 (en) Polyrotaxane and medicinal composition
EP3049711A4 (en) Pressure isolation manifold
EP3008243A4 (en) Layered tissue structures comprising macroalgae
EP3019451A4 (en) Highly porous aerogels
IL244011A0 (en) Intra-abdominal pressure to promote hemostasis and survival
EP3060061A4 (en) Use of probiotics in meat
EP3063000A4 (en) Durable creped tissue
EP3060924A4 (en) Pif-transfected cells and methods of use
EP3037052A4 (en) Trocar
EP3063383A4 (en) Supercharger having pre-boosting configuration
EP3027182A4 (en) Novel copper-cysteamine and methods of use
EP3066988A4 (en) Skin dilator

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160219

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170711

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/00 20060101AFI20170706BHEP

Ipc: A61B 5/02 20060101ALI20170706BHEP

Ipc: A61B 5/022 20060101ALI20170706BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180208